Former Czar Calls Sanders’ Plan a Tax, Warns on AI Stakes
A high-profile former AI czar challenges Sanders’ 50% government stake plan for AI firms, warning that nationalizatio...
Why Every Young Adult Should Budget
Budgeting is essential for young adults to manage expenses and save for the future. Discover the benefits of budgeting early in life.
26,307 articlesSpaceX Already Needs More Cash: IPO Stock Implications
SpaceX is expanding fast after its IPO, but new debt plans and strategic bets raise questions for investors. This art...
General Mills (GIS) 2026: Earnings Outlook and Strategy
General Mills faces a turning point in 2026. This in-depth look examines earnings drivers, margins, and cash returns,...
Costco Just Signed Massive Florida Deal: Investors
Costco just signed massive Florida land deal signals a bold expansion move. This article breaks down what it means fo...
Microsoft Distancing Itself From OpenAI Could Help Investors
As AI accelerates, the Microsoft-OpenAI relationship faces shifts. This piece explains why microsoft distancing itsel...
Does Micron's Improved Price Make Sense After Earnings?
Micron burst higher after a strong earnings report, but does micron's improved price truly reflect durable fundamenta...
Enhabit (EHAB) 2025 Earnings Outlook: Key Takeaways
As Enhabit prepares to report its first-quarter results, investors need a clear playbook. This guide breaks down what...
Innovate (VATE) 2026 Earnings: Key Takeaways for Investors
As the first-quarter report for Innovate lands, investors eye more than just the top line. This guide breaks down wha...
C3.ai's Sold 17,350 Shares: What Investors Should Know
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
XLRE Keeps Real Estate Costs Low, RWO Expands Reach
Two popular real estate ETFs offer distinct paths: XLRE provides a low-cost U.S. core, while RWO adds global reach. L...
This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Alumis Stock Over 300%: What Investors Should Know Now
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status